Bio-Techne Corp (TECH) Social Stream
BIO-TECHNE CORP (TECH) Price Targets From Analysts
Use the tables below to see what analysts covering BIO-TECHNE CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 9 | $600 | $400 | $510.625 | $68.43 | 646.2% |
| 2021-12-01 | 9 | $600 | $400 | $511.875 | $68.43 | 648.03% |
| 2022-02-01 | 9 | $600 | $400 | $506.25 | $68.43 | 639.81% |
| 2022-03-01 | 6 | $600 | $540 | $565 | $68.43 | 725.66% |
| 2022-04-25 | 7 | $600 | $370 | $532.5 | $68.43 | 678.17% |
| 2022-05-05 | 7 | $575 | $370 | $515.833 | $68.43 | 653.81% |
| 2022-06-06 | 7 | $575 | $370 | $506.428 | $68.43 | 640.07% |
| 2022-08-04 | 6 | $580 | $370 | $507.142 | $68.43 | 641.11% |
| 2022-08-05 | 6 | $580 | $370 | $491.428 | $68.43 | 618.15% |
| 2022-09-22 | 6 | $580 | $360 | $490 | $68.43 | 616.06% |
| 2022-10-19 | 6 | $550 | $360 | $485.714 | $68.43 | 609.8% |
| 2022-11-01 | 6 | $550 | $360 | $477.142 | $68.43 | 597.27% |
| 2022-11-02 | 6 | $500 | $360 | $442.5 | $68.43 | 546.65% |
| 2022-12-05 | 6 | $125 | $90 | $110.625 | $68.43 | 61.66% |
| 2022-12-07 | 7 | $125 | $89 | $108.222 | $68.43 | 58.15% |
| 2022-12-12 | 8 | $125 | $89 | $107.4 | $68.43 | 56.95% |
| 2023-01-06 | 9 | $125 | $89 | $106.727 | $68.43 | 55.97% |
| 2023-02-03 | 9 | $125 | $89 | $106.727 | $68.43 | 55.97% |
| 2023-02-14 | 9 | $120 | $88 | $103.227 | $68.43 | 50.85% |
| 2023-03-27 | 9 | $120 | $88 | $102.772 | $68.43 | 50.19% |
| 2023-05-01 | 8 | $120 | $88 | $102.772 | $68.43 | 50.19% |
| 2023-05-04 | 9 | $120 | $90 | $102.954 | $68.43 | 50.45% |
| 2023-08-09 | 9 | $120 | $90 | $103.045 | $68.43 | 50.58% |
| 2023-08-16 | 9 | $120 | $90 | $102.159 | $68.43 | 49.29% |
| 2023-08-25 | 10 | $120 | $90 | $102.159 | $68.43 | 49.29% |
| 2023-09-12 | 11 | $120 | $90 | $102.159 | $68.43 | 49.29% |
| 2023-09-22 | 11 | $120 | $86 | $101.795 | $68.43 | 48.76% |
The Trend in the Analyst Price Target
TECH's average price target has moved down $1.25 over the prior 53 days.
TECH reports an average of 30.4% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-09 | 9 | 120 | 90 | 103.045 | 83.00 | 24.15% |
| 2023-08-25 | 10 | 120 | 90 | 102.159 | 80.16 | 27.44% |
| 2023-09-01 | 11 | 120 | 90 | 102.159 | 78.76 | 29.71% |
| 2023-09-11 | 11 | 120 | 90 | 102.159 | 71.63 | 42.62% |
| 2023-09-20 | 11 | 120 | 86 | 101.795 | 70.87 | 43.64% |
TECH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 9 | 0 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 14 months, TECH's average broker recommendation rating improved by 0.31.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, BIO-TECHNE CORP's average analyst price target is greater than 3147.34% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, BIO-TECHNE CORP's upside potential (average analyst target price relative to current price) is higher than 3136.43% of them.
- TECH has a greater number of analysts covering the stock than 578.21% of stocks in the large market cap category.
- In the context of Pharmaceutical Products stocks, BIO-TECHNE CORP's variance in analysts' estimates is lower than -600.9% of them.
Stocks similar to BIO-TECHNE CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RGEN, DNA, and CGC.
View All Top Stocks by Price Target
Is TECH a Buy, Hold or Sell? See the POWR Ratings now!